NPAL1 activators are a class of chemical compounds that interact with the neural palmitoyl-transferase 1 (NPAL1) enzyme, a member of the palmitoyltransferase family. This enzyme is involved in the post-translational modification of proteins through a process known as palmitoylation, which attaches a palmitoyl group (found in palmitic acid) to specific cysteine residues on target proteins. This lipid modification can influence the localization, stability, and function of the protein substrates. NPAL1 activators influence this enzyme's activity by increasing its catalytic efficiency or by stabilizing its active form, thereby potentially altering the palmitoylation status of numerous cellular proteins. The activation of NPAL1 can lead to a cascade of molecular events, as the modification of protein function via palmitoylation is a reversible and dynamic process that plays a role in various cellular mechanisms, including signal transduction, membrane trafficking, and subcellular localization.
The specificity of NPAL1 activators lies in their ability to target and modulate the activity of the NPAL1 enzyme without necessarily interacting with other palmitoyltransferases or unrelated enzymatic pathways. The chemical structure of these activators is designed to interact with the unique active site or regulatory domains of NPAL1, taking advantage of the enzyme's structure to achieve selectivity. This interaction may involve various non-covalent bonds, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, to induce a conformational change in the enzyme that promotes its activity. The molecular design of NPAL1 activators is a sophisticated process that requires a deep understanding of the enzyme's structure and the chemical properties that can enhance its natural function. These compounds can be small molecules, peptides, or other types of chemical entities that have been optimized through structure-activity relationship studies to maximize their efficacy in modulating the enzyme. The development of NPAL1 activators entails a comprehensive evaluation of their physicochemical properties, stability, and specificity to ensure they selectively engage with NPAL1.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a diacylglycerol analog which activates Protein Kinase C (PKC). PKC has been implicated in the phosphorylation and subsequent activation of NPAL1, leading to enhanced functional activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin works by activating adenylyl cyclase, thereby increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate and activate NPAL1. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which can activate calcium-dependent protein kinases that phosphorylate and enhance NPAL1 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a polyphenol that can inhibit certain protein kinases, potentially altering the phosphorylation state and activity of proteins upstream of NPAL1, leading to its enhanced activation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, which can lead to downstream activation of NPAL1 through protein kinase cascades. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
cAMP is a second messenger that activates PKA. PKA phosphorylation targets may include NPAL1, thereby enhancing its activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins, which may include NPAL1, thereby enhancing its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases (SAPKs), which may lead to the phosphorylation and activation of NPAL1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA. Activation of PKA may result in phosphorylation and enhancement of NPAL1 activity. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $104.00 $239.00 $409.00 | ||
Phosphatidic acid is a lipid signaling molecule that can activate mTOR signaling pathways, potentially leading to the activation of NPAL1. |